definiens: shall mean the equit y financing from the sale of Series A Preferred Stock of Neurotrope, par value $ 0.01 per share pursuant to the closing of the transactions contemplated by the Founder Purchase A greements and Inves tor Purchase Agreement and the actual receipt of the proceeds therefrom by Neu rotrope ( following approval of such receipt by BRNI ), it being understood that for the purposes of Sectio n 1.16, Section 11.2.1 and Article 12, Neurotrope ’s obligations with resp ect to the A Round Financing shall not be considere d satisfied, and the A Round Financing shall not be considered completed, until the Net Amount of such proceeds is equal to or grea ter than eight million dollars ( $ 8,000,000 ) ( or such ot her amount as agree d by a unanimous vote of all of the Directors ( as defined in the Stockholders Agreement ) of the Board ( as defined in the Stockholders Agreement ) )